4//SEC Filing
Lubman Ellen 4
Accession 0000950170-25-002362
CIK 0001785530other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:51 PM ET
Size
5.5 KB
Accession
0000950170-25-002362
Insider Transaction Report
Form 4
Lubman Ellen
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-02+131,900→ 131,900 totalExercise: $1.56Exp: 2034-12-31→ Common Stock (131,900 underlying)
Footnotes (1)
- [F1]The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001857842
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:51 PM ET
- Size
- 5.5 KB